US2024018469A1PendingUtilityA1

Cellular microcompartment and preparation processes

78
Assignee: UNIV BORDEAUXPriority: Nov 23, 2016Filed: Sep 29, 2023Published: Jan 18, 2024
Est. expiryNov 23, 2036(~10.4 yrs left)· nominal 20-yr term from priority
A01N 1/162C12N 5/0075C12M 23/20C12M 25/01C12M 25/16C12N 5/0012C12N 5/0696C12N 2501/727C12N 2513/00C12N 2533/74C12N 2533/90C12N 2535/00C12N 5/0068
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a cellular microcompartment comprising successively, organized around a lumen, at least one layer of pluripotent cells, an extracellular matrix layer and an outer hydrogel layer. The invention also relates to processes for preparing such cellular microcompartments.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A cellular microcompartment comprising successively, organized around a lumen:
 at least one layer of human pluripotent cells, wherein the human pluripotent cells are polarized and the inner/apical side of the pluripotent cell layer is adjacent to the lumen;   an extracellular matrix layer; an outer hydrogel layer, wherein said outer layer thickness is between 5 to 40 μm.   
     
     
         2 . The cellular microcompartment according to  claim 1 , wherein said microcompartment is closed. 
     
     
         3 . The cellular microcompartment according to  claim 1 , wherein the cell density is between one and several thousand cells per microcompartment. 
     
     
         4 . The cellular microcompartment according to  claim 1 , wherein the outer layer comprises alginate. 
     
     
         5 . The cellular microcompartment according to  claim 1 , wherein the outer layer comprises alginate more than 80% of α-L-guluronate and less than 20% of β-D-mannuronate. 
     
     
         6 . The cellular microcompartment according to  claim 1 , wherein hydrogel layer is alginate with an average molecular mass of 100 to 400 KDa. 
     
     
         7 . The cellular microcompartment according to  claim 1 , wherein said microcompartment has a spherical or elongated shape. 
     
     
         8 . The cellular microcompartment according to  claim 1 , wherein said microcompartment has a diameter or a smallest dimension comprised between 10 μm and 1 mm, preferentially between 50 μm and 500 μm, more preferentially less than 500 μm, even more preferentially less than 400 μm. 
     
     
         9 . The cellular microcompartment according to  claim 1 , wherein the cell density is comprised between one and several thousand cells, preferentially 50 to 1000 cells per microcompartment. 
     
     
         10 . The cellular microcompartment according to  claim 1 , wherein the thickness of the extracellular matrix layer represents 5 to 80% of the radius of the microcompartment. 
     
     
         11 . The cellular microcompartment according to  claim 1 , wherein the extracellular matrix layer is attached to the inner side of the hydrogel shell. 
     
     
         12 . A method for preparing a cellular microcompartment of  claim 1 , the method comprising:
 (a) incubating human pluripotent stem cells in a culture medium containing a RHO/ROCK pathway inhibitor;   (b) mixing the pluripotent stem cells from step (a) with an extracellular matrix;   (c) encapsulating the mixture from step (b) in a hydrogel layer;   (d) culturing the capsules obtained in step (c) in a culture medium containing a RHO/ROCK pathway inhibitor;   (e) rinsing the capsules from step (d) to remove the RHO/ROCK pathway inhibitor;   (f) culturing the capsules from step (e) for 3 to 20 days or for 5 to 10 days, and optionally recovering the cellular microcompartments.   
     
     
         13 . The method of  claim 12  further comprising
 dissociating the pluripotent stem cells from step (a) before step (b) by contacting the pluripotent stem cells with an enzyme-free reagent. 
 
     
     
         14 . A method for preparing a cellular microcompartment of  claim 1 , comprising the steps consisting of:
 (a) mixing human differentiated cells with an extracellular matrix and cell reprogramming agents;   (b) encapsulating the mixture from step (a) in a hydrogel layer;   (c) culturing the capsules from step (b) for 10 to 40 days, and optionally recovering the cellular microcompartments obtained.   
     
     
         15 . The method of  claim 14 , wherein each capsule from step (b) contains between 1 and 500 differentiated cells. 
     
     
         16 . The method of  claim 12 , wherein the method further comprises freezing the cellular microcompartments obtained in step (f). 
     
     
         17 . The method of  claim 14 , wherein the method further comprises freezing the cellular microcompartments obtained in step (c).

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.